Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment

Inclusion Criteria: * Patients aged ≥ 40 years. * Osteoarthritis of the hand according to American College of Rheumatology criteria 1990 * Osteoarthritis affecting at least two proximal and/or distal interphalangeal joints with a radiological Kellgren-Lawrence stage ≥ 2. * Symptomatic osteoarthritis within the last 3 months. * Visual analogue pain scale of the hand to be treated ≥ 40/100 mm (most painful hand). * Inadequate response, adverse effects and/or contraindication to NSAIDs and non-opioid analgesics. * Patient affiliated to french social security or a similar health assurance. Exclusion Criteria: * History of allergy to iodinated contrast media, LipiodolⓇ or poppies. * Vasomotor disorders (Raynaud\'s syndrome, scleroderma, acrocyanosis). * Stenosis (\>50%) or known atheromatous arterial occlusion of the upper limbs. * Obliterative arterial disease of the lower limbs at the critical ischaemia stage. * Severe to end-stage chronic renal insufficiency (glomerular filtration rate \< 30ml/min/1.73m2), dialysis or renal transplant. * Arteritis such as thromboangiitis obliterans disease or other diseases * Previous thrombosis/dissection of the radial artery. * Chronic inflammatory rheumatic disease (rheumatoid arthritis, psoriatic arthritis, microcrystalline arthritis, etc.). * Known hyperthyroidism or large multinodular goiter. * Traumatic lesions, haemorrhages or chronic bleeding in the hand (not completely resolved within 3 months of the start of the lesion) requiring embolisation. * Pregnant or breast-feeding. * Patients covered by articles L1121-5 to L1121-8 of the French Public Health Code and/or who do not speak French. * Patients in a period of exclusion or in the course of another interventional clinical trial.